Literature DB >> 23585338

The role of TGF-β in polycystic ovary syndrome.

Nazia Raja-Khan1, Margrit Urbanek, Raymond J Rodgers, Richard S Legro.   

Abstract

Polycystic ovary syndrome (PCOS) is a common endocrine disorder characterized by chronic oligoanovulation and hyperandrogenism and associated with insulin resistance, type 2 diabetes, and cardiovascular risk. In recent years, genetic studies have linked PCOS to a dinucleotide marker D19S884 in the fibrillin 3 gene. Fibrillins make up the major component of microfibrils in the extracellular matrix (ECM) and interact with molecules in the ECM to regulate transforming growth factor β (TGF-β) signaling. Therefore, variations in fibrillin 3 and subsequent dysregulation of TGF-β may contribute to the pathogenesis of PCOS. Here, we review the evidence from genetic studies supporting the role of TGF-β in PCOS and describe how TGF-β dysregulation may contribute to (1) the fetal origins of PCOS, (2) reproductive abnormalities in PCOS, and (3) cardiovascular and metabolic abnormalities in PCOS.

Entities:  

Keywords:  TGF-β; fetal origins; fibrillin; genetics; polycystic ovary syndrome

Mesh:

Substances:

Year:  2013        PMID: 23585338      PMCID: PMC5933191          DOI: 10.1177/1933719113485294

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  111 in total

Review 1.  Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia.

Authors:  Razi Khan; Richard Sheppard
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

2.  50th anniversary of aldosterone.

Authors:  Jonathan S Williams; Gordon H Williams
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

3.  Physical properties of alginate hydrogels and their effects on in vitro follicle development.

Authors:  Erin R West; Min Xu; Teresa K Woodruff; Lonnie D Shea
Journal:  Biomaterials       Date:  2007-07-23       Impact factor: 12.479

4.  Association study of four key folliculogenesis genes in polycystic ovary syndrome.

Authors:  K Sproul; M R Jones; R Mathur; R Azziz; M O Goodarzi
Journal:  BJOG       Date:  2010-03-12       Impact factor: 6.531

5.  Fibrillins in adult human ovary and polycystic ovary syndrome: is fibrillin-3 affected in PCOS?

Authors:  C Diana Jordan; Sandra D Bohling; Noe L Charbonneau; Lynn Y Sakai
Journal:  J Histochem Cytochem       Date:  2010-10       Impact factor: 2.479

6.  Null mutation in transforming growth factor beta1 disrupts ovarian function and causes oocyte incompetence and early embryo arrest.

Authors:  Wendy V Ingman; Rebecca L Robker; Karen Woittiez; Sarah A Robertson
Journal:  Endocrinology       Date:  2005-11-03       Impact factor: 4.736

7.  Differential gene expression in granulosa cells from polycystic ovary syndrome patients with and without insulin resistance: identification of susceptibility gene sets through network analysis.

Authors:  Surleen Kaur; Kellie J Archer; M Gouri Devi; Alka Kriplani; Jerome F Strauss; Rita Singh
Journal:  J Clin Endocrinol Metab       Date:  2012-08-17       Impact factor: 5.958

Review 8.  TGF-beta in renal injury and disease.

Authors:  Erwin P Böttinger
Journal:  Semin Nephrol       Date:  2007-05       Impact factor: 5.299

9.  Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome.

Authors:  Paul J Coucke; Andy Willaert; Marja W Wessels; Bert Callewaert; Nicoletta Zoppi; Julie De Backer; Joyce E Fox; Grazia M S Mancini; Marios Kambouris; Rita Gardella; Fabio Facchetti; Patrick J Willems; Ramses Forsyth; Harry C Dietz; Sergio Barlati; Marina Colombi; Bart Loeys; Anne De Paepe
Journal:  Nat Genet       Date:  2006-03-19       Impact factor: 38.330

10.  Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage.

Authors:  M Suthanthiran; B Li; J O Song; R Ding; V K Sharma; J E Schwartz; P August
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

View more
  34 in total

Review 1.  Steroidogenic versus Metabolic Programming of Reproductive Neuroendocrine, Ovarian and Metabolic Dysfunctions.

Authors:  Rodolfo C Cardoso; Muraly Puttabyatappa; Vasantha Padmanabhan
Journal:  Neuroendocrinology       Date:  2015-04-01       Impact factor: 4.914

Review 2.  Extracellular microRNA profiling in human follicular fluid: new biomarkers in female reproductive potential.

Authors:  Maryam Qasemi; Fardin Amidi
Journal:  J Assist Reprod Genet       Date:  2020-07-09       Impact factor: 3.412

3.  Single nucleotide polymorphisms in the TGF-β1 gene are associated with polycystic ovary syndrome susceptibility and characteristics: a study in Korean women.

Authors:  Eun Youn Roh; Jong Hyun Yoon; Eun Young Song; Jin Ju Kim; Kyu Ri Hwang; Soo Hyun Seo; Sue Shin
Journal:  J Assist Reprod Genet       Date:  2016-10-29       Impact factor: 3.412

4.  Could perturbed fetal development of the ovary contribute to the development of polycystic ovary syndrome in later life?

Authors:  Monica D Hartanti; Roseanne Rosario; Katja Hummitzsch; Nicole A Bastian; Nicholas Hatzirodos; Wendy M Bonner; Rosemary A Bayne; Helen F Irving-Rodgers; Richard A Anderson; Raymond J Rodgers
Journal:  PLoS One       Date:  2020-02-20       Impact factor: 3.240

5.  PAI-1 in granulosa cells is suppressed directly by statin and indirectly by suppressing TGF-β and TNF-α in mononuclear cells by insulin-sensitizing drugs.

Authors:  Kaori Yamada-Nomoto; Osamu Yoshino; Ikumi Akiyama; Akira Iwase; Yosuke Ono; Tomoko Nakamura; Miyuki Harada; Akitoshi Nakashima; Tomoko Shima; Akemi Ushijima; Yutaka Osuga; Russell Jeffrey Chang; Shunichi Shimasaki; Shigeru Saito
Journal:  Am J Reprod Immunol       Date:  2017-03-24       Impact factor: 3.886

Review 6.  Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.

Authors:  Daniel A Dumesic; Sharon E Oberfield; Elisabet Stener-Victorin; John C Marshall; Joop S Laven; Richard S Legro
Journal:  Endocr Rev       Date:  2015-10       Impact factor: 19.871

7.  Adipose Insulin Resistance in Normal-Weight Women With Polycystic Ovary Syndrome.

Authors:  Daniel A Dumesic; Julia D Phan; Karen L Leung; Tristan R Grogan; Xiangmiang Ding; Xinmin Li; Luis R Hoyos; David H Abbott; Gregorio D Chazenbalk
Journal:  J Clin Endocrinol Metab       Date:  2019-06-01       Impact factor: 5.958

8.  Gonadal soma controls ovarian follicle proliferation through Gsdf in zebrafish.

Authors:  Yi-Lin Yan; Thomas Desvignes; Ruth Bremiller; Catherine Wilson; Danielle Dillon; Samantha High; Bruce Draper; Charles Loren Buck; John Postlethwait
Journal:  Dev Dyn       Date:  2017-09-25       Impact factor: 3.780

Review 9.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Authors:  Robert L Rosenfield; David A Ehrmann
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

10.  Fibroinflammatory Signatures Increase with Age in the Human Ovary and Follicular Fluid.

Authors:  Jordan H Machlin; Seth J Barishansky; John Kelsh; Megan J Larmore; Brian W Johnson; Michele T Pritchard; Mary Ellen Pavone; Francesca E Duncan
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.